About PinCell
PinCell is a company based in Milano (Italy) founded in 2008 by Carlo Pincelli and Alessandra Marconi was acquired by Scinai in March 2025. PinCell has raised $1.78 million across 1 funding round from investors including Scinai and Sofinnova Partners. PinCell offers products and services including Anti-inflammatory Therapy. PinCell operates in a competitive market with competitors including ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and Forte Biosciences, among others.
- Headquarter Milano, Italy
- Founders Carlo Pincelli, Alessandra Marconi
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pincell S.R.L.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PinCell
PinCell offers a comprehensive portfolio of products and services, including Anti-inflammatory Therapy.
Develops therapies targeting skin disease pathways with high unmet needs
People of PinCell
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of PinCell
PinCell has successfully raised a total of $1.78M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.78 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PinCell
PinCell has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Scinai and Sofinnova Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Provider of immuno-therapeutics solutions for the healthcare industry
|
Locked | Locked | Locked |
Investor details for PinCell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PinCell
Investment portfolio details for PinCell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PinCell
Detailed financials for PinCell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pincell Comparisons
Peer comparison for PinCell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PinCell
PinCell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ASLAN Pharmaceuticals, Concerto Biosciences, UNION Therapeutics, Biosion and Forte Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Targeted small molecules are developed for oncology treatments.
|
|
| Locked | Locked | Locked |
Microbe-based products are developed for agriculture and human health.
|
|
| Locked | Locked | Locked |
Small molecule antibiotics are developed for bacterial infections.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for inflammatory skin diseases are developed.
|
Detailed competitors of PinCell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pincell
Complete news archive for PinCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PinCell
PinCell was founded in 2008 and raised its 1st funding round 12 years after it was founded.
PinCell is headquartered in Milano, Italy.
PinCell is a funded company, having raised a total of $1.78M across 1 funding round to date.
Pincell develops anti-inflammatory therapy for the treatment of skin diseases. It provides treatments for different dermatological disorders particularly chronic inflammatory orphan diseases of the skin. They have developed the drug by targeting pathways involved in the pathomechanism.
PinCell's top competitors include ASLAN Pharmaceuticals, Concerto Biosciences and UNION Therapeutics.
PinCell offers Anti-inflammatory Therapy.
PinCell has 2 investors. Key investors include Scinai, and Sofinnova Partners.